Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Net Debt Paydown Yield % is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. It is a measure of a company's willingness and ability to reduce its debt.
As of today, St Pharm Co's Net Debt Paydown Yield % was 2.24%.
St Pharm Co (XKRX:237690) Net Debt Paydown Yield % Explanation
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced. In other words, it is a measure of the willingness and ability of a firm's management to pay down debt. Companies that have high debt paydown yields indicate that they are more aggressive with paying down debt.
In the calculation of Net Debt Paydown Yield %, we use the reductions of TTM average total debt one-year-ago and TTM average total debt at present, divided by its Market Cap.
St Pharm Co Net Debt Paydown Yield % Related Terms
St Pharm Co Net Debt Paydown Yield % Historical Data
* Premium members only.
The historical data trend for St Pharm Co's Net Debt Paydown Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:237690 vs ZTS: Net Debt Paydown Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, St Pharm Co's Net Debt Paydown Yield %, along with its competitors' market caps and Net Debt Paydown Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
St Pharm Co Net Debt Paydown Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, St Pharm Co's Net Debt Paydown Yield % distribution charts can be found below:
* The bar in red indicates where St Pharm Co's Net Debt Paydown Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Net Debt Paydown Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
What does a Net Debt Paydown Yield % of 2.24% mean?
St Pharm Co (XKRX:237690) has a Net Debt Paydown Yield % of 2.24% as of Sep. 21, 2026. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on St Pharm Co and its competitors. According to the industry distribution chart, St Pharm Co ranks #189 out of 920 companies in the Drug Manufacturers industry, placing it in the top 20.5%.
Is St Pharm Co's Net Debt Paydown Yield % too high?
St Pharm Co's current Net Debt Paydown Yield % is 2.24%. Based on the distribution chart, St Pharm Co ranks #189 out of 920 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, St Pharm Co has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does St Pharm Co's Net Debt Paydown Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, St Pharm Co ranks #189 out of 920 companies for Net Debt Paydown Yield %. This places St Pharm Co in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Debt Paydown Yield % for a Drug Manufacturers company?
A good Net Debt Paydown Yield % depends on the Drug Manufacturers industry context. However, Net Debt Paydown Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Debt Paydown Yield % mean?
A high Net Debt Paydown Yield % can signal that a stock is expensive relative to its fundamentals. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on St Pharm Co and its competitors. St Pharm Co's current Net Debt Paydown Yield % is 2.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is St Pharm Co stock overvalued right now?
Based on GuruFocus' analysis, St Pharm Co (XKRX:237690) is currently considered Modestly Undervalued. The stock's GF Value™ is ₩115,775.72, compared to a current price of ₩92,700.00 — trading 19.9% below its estimated fair value. The current Net Debt Paydown Yield % is 2.24%. St Pharm Co's overall GF Score™ is 95/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Debt Paydown Yield % calculated?
Net Debt Paydown Yield % is calculated from a company's financial statements. For St Pharm Co (XKRX:237690), the current Net Debt Paydown Yield % is 2.24% as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is St Pharm Co (XKRX:237690) Overvalued in 2026?
Based on GuruFocus' analysis, St Pharm Co stock appears to be undervalued.
The current stock price of ₩92,700.00 is trading 19.9% below its estimated GF Value™ of ₩115,775.72.
GuruFocus considers St Pharm Co to be Modestly Undervalued.
Key valuation signals for XKRX:237690:
Net Debt Paydown Yield %: 2.24%
GF Value™: ₩115,775.72 vs. price of ₩92,700.00 (19.9% below fair value)
No single metric tells the full story. See the XKRX:237690 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
St Pharm Co Ltd offers custom manufacturing services of Active pharmaceutical ingredients and their intermediates for their use in pharmaceutical development and be compliant to cGMP, requirements. The firm's business areas include commercial manufacturing of new drug development, manufacturing of generic active pharmaceutical ingredients, fine chemical's business and development of oligonucleotide therapeutics. The company's products comprise small molecule active pharmaceutical ingredients, Anti-cancer, Anti- coagulant active pharmaceutical ingredients, etc.
95GF Score
Get the complete analysis for XKRX:237690
Net Debt Paydown Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:237690 has been successfully added to your 
